818-819 / 2605
‹#›
Conclusion:
Role of Proton Therapy in NSCLC is still emerging
Emerging benefits in improved acute and early-late tolerance of
combined modality therapy
Largest benefit in central locations
Appropriate tool for focused re-irradiation
Given the problems of conventional photons to accomplish SAFE
dose escalation in Central Lung Cancer, protons might be the tool to
accomplish dose escalation
Consensus statement of proton therapy in early stage and locally advanced
non–small cell lung cancer
Joe Y. Chang, Jeffrey D. Bradley, Brad S. Hoppe et al
On behalf of the Thoracic Subcommittee of PTCOG
IJROBP 2016